To our knowledge, IMPROVE-T2D is the first study to examine glucose and insulin homeostasis, body composition, cardiovascular risk markers, REE and nutrient oxidation, or incretin response in youth with type 2 diabetes undergoing VSG, and to do so in a prospective design. The gene discussed is GCG; the disease is type 2 diabetes mellitus.